Company Diafarma Srl with Fiscal Code 18631888
recorded a turnover of 2024 of
39.395,
with a net profit of
-1.026
and having an average number of employees of
1.
The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Diafarma Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
45.231
43.169
43.243
49.966
43.502
36.584
31.710
32.483
37.726
39.395
Total Income - EUR
45.234
43.170
43.633
49.966
43.503
37.014
33.120
34.742
41.568
42.228
Total Expenses - EUR
43.645
41.272
43.082
50.707
48.133
36.518
32.857
34.331
39.807
42.858
Gross Profit/Loss - EUR
1.588
1.898
551
-740
-4.629
496
263
412
1.761
-631
Net Profit/Loss - EUR
92
933
67
-1.281
-5.097
224
55
63
1.346
-1.026
Employees
1
1
1
1
1
1
1
1
1
1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 5.0%, from 37.726 euro in the year 2023, to 39.395 euro in 2024.
The Net Profit decreased by -1.338 euro, from 1.346 euro in 2023, to 0 in the last year.
Check the financial reports for the company - Diafarma Srl
Financial Rating - DIAFARMA SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Diafarma Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Diafarma Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Diafarma Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
21.145 euro in 2024 which includes Inventories of
9.237 euro, Receivables of
7.994 euro and cash availability of
3.913 euro.
The company's Equity was valued at
9.187 euro, while total Liabilities amounted to
11.958 euro.
Equity decreased by -1.026 euro, from 10.271 euro in 2023, to 9.187 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Diafarma Srl